Your browser doesn't support javascript.
loading
Liver Function Tests and FIB-4 Score as Predictors of Severity in COVID-19 Patients from the South-West of Romania.
Kamal, Adina M; Dumitrescu, Florentina; Mita, Adrian; Sabiescu, Denisa M; Alexandru, Dragoș O; Gheorghe, Codruța E; Filip, Monalisa M; Ionescu-Ciocâlteu, Adriana; Maria, Daniela T; Kamal, Diana; Kamal, Constantin K.
Afiliación
  • Kamal AM; Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Dumitrescu F; Department of Infectious Disease, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Mita A; Department of Clinical Semiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Sabiescu DM; Department of Infectious Disease, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Alexandru DO; Department of Informatics and Biostatistics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Gheorghe CE; Department of Family Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Filip MM; Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Ionescu-Ciocâlteu A; Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Maria DT; Department of Nephrology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Kamal D; Department of Physical and Rehabilitation Medicine, Filantropia Municipal Hospital Craiova, 200516 Craiova, Romania.
  • Kamal CK; Department of Family Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Life (Basel) ; 12(7)2022 Jun 22.
Article en En | MEDLINE | ID: mdl-35888026
ABSTRACT

BACKGROUND:

The coronavirus disease 2019 pandemic (COVID-19) is the most important global health crisis to date. In this study, we performed an analysis to find the association between liver damage, FIB-4 score and the severity of COVID-19 disease.

METHODS:

We included a total of 580 patients that tested positive for SARS-CoV-2 infection and were hospitalized. No patient included had any known history of liver disease. Liver function tests were performed, and FIB-4 score was calculated in order to assess their involvement in the disease progression.

RESULTS:

More than half of the patients had elevated liver function tests. Age, high body mass index, associated heart disease and diabetes were associated with poor outcome. Corticosteroids, antibiotics, and anticoagulants strongly correlated with liver injuries. Liver impairment and injury, as well as a FIB-4 score higher than 3.5, also correlated with higher degrees of disease severity.

CONCLUSION:

Liver injury and elevated FIB-4 score were associated with poor clinical outcome and disease severity, as well as being a valuable tool to predict COVID-19-related mortality.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Life (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Rumanía

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Life (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Rumanía